Stockscreener 앱 받기
1.95
1.56%
0.03
시간 외 거래:
1.93
-0.02
-1.03%
전일 마감가:
$1.92
열려 있는:
$1.92
하루 거래량:
795.58K
Relative Volume:
0.25
시가총액:
$51.84M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-1.1677
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
-3.94%
1개월 성능:
-27.51%
6개월 성능:
-76.16%
1년 성능:
-67.50%
1일 변동 폭
$1.855
$2.00
1주일 범위
$1.855
$2.08
52주 변동 폭
$1.855
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.95 | 51.04M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-01 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
INmune Bio Inc. stock trend forecastJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Technical signs of recovery in INmune Bio Inc.Quarterly Profit Summary & High Accuracy Investment Entry Signals - Newser
What is INmune Bio Inc.’s book value per shareJuly 2025 Drop Watch & AI Based Trade Execution Alerts - خودرو بانک
Is INmune Bio Inc. stock a falling knife or bargain buyJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک
Relative strength of INmune Bio Inc. in sector analysisTrade Risk Summary & Daily Technical Forecast Reports - Newser
Is INmune Bio Inc. stock a value trap2025 Pullback Review & Weekly Watchlist of Top Performers - خودرو بانک
What momentum shifts mean for INmune Bio Inc.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
Technical signs of recovery in INmune Bio Inc2025 Price Action Summary & Momentum Based Trading Ideas - Newser
What’s next for INmune Bio Inc. stock priceJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Detecting price anomalies in INmune Bio Inc. with AIExit Point & Risk Controlled Swing Alerts - Newser
Can INmune Bio Inc. rally from current levelsPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - Newser
What makes INmune Bio Inc. stock price move sharplyJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
What to do if you’re stuck in INmune Bio Inc.Stock Surge & Free High Accuracy Swing Entry Alerts - Newser
News impact scoring models applied to INmune Bio Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - Newser
Will INmune Bio Inc. outperform the market in YEARTrade Exit Report & Daily Technical Stock Forecast Reports - خودرو بانک
Evaluating INmune Bio Inc. with trendline analysisQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Can swing trading help recover from INmune Bio Inc. lossesJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
INmune Bio Inc.’s volatility index tracking explainedGold Moves & Verified Momentum Stock Alerts - Newser
Inmune Bio Inc. shares rise 1.02% premarket after Tevogen Bio Holdings Inc. highlights the importance of SARS-CoV-2 treatments for weakened immune systems. - AInvest
Visual analytics tools that track INmune Bio Inc. performanceQuarterly Trade Review & Community Consensus Trade Alerts - Newser
Will INmune Bio Inc. be affected by tariffs2025 Trade Ideas & Entry Point Strategy Guides - خودرو بانک
Can you recover from losses in INmune Bio Inc.Treasury Yields & Advanced Swing Trade Entry Alerts - Newser
Will INmune Bio Inc. outperform tech stocksJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - خودرو بانک
Backtesting results for INmune Bio Inc. trading strategiesJuly 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Is INmune Bio Inc. stock bottoming outOptions Play & Fast Gain Stock Trading Tips - Newser
Is INmune Bio Inc. forming a double bottomStock Surge & Weekly Return Optimization Plans - خودرو بانک
Real time social sentiment graph for INmune Bio Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Is INmune Bio Inc. stock reversal real or fake2025 Market WrapUp & Community Trade Idea Sharing - Newser
Is INmune Bio Inc. still worth holding after the dipWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Geopolitics Watch: Is INmune Bio Inc. showing insider buying2025 Macro Impact & Weekly Market Pulse Updates - خودرو بانک
What data driven models say about INmune Bio Inc.’s future2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can INmune Bio Inc. recover in the next quarterJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
Analyzing INmune Bio Inc. with multi timeframe chartsJuly 2025 Closing Moves & Stepwise Trade Execution Plans - Newser
Tools to monitor INmune Bio Inc. recovery probability2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Should I hold or sell INmune Bio Inc. now2025 Top Decliners & Stepwise Swing Trade Plans - خودرو بانک
Is INmune Bio Inc. impacted by rising ratesMarket Performance Report & High Conviction Buy Zone Alerts - خودرو بانک
Can INmune Bio Inc. hit a new high this month2025 Price Targets & Safe Entry Trade Signal Reports - Newser
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):